The Importance of Early Recognition and Treatment Initiation for Managing Alzheimer's disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial

Lecanemab Maintenance Dosing in Early Alzheimer’s Disease: Support for Continued Dosing from Clinical, Pharmacology, and Modeling Data